跳到主要內容

Trilogy Equity Partners, LLC 的 Form 4 申報

Owlet, Inc.OWLT,2024/3/1 申報

申報編號
0000950170-24-023912
申報時間
2024/3/1
交易日
2024/2/29
申報延遲
1 天
10b5-1 計畫
沒有勾選

這份申報列了 2 筆衍生性交易。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Trilogy Equity Partners, LLCCIK 0001875623持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

這份申報沒有這一類的交易。

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2024/2/29Class A Common StockP買進取得+296,401$1,000.00F1+$2,286,0002,286直接
2024/2/29Class A Common StockP買進取得+444,601–F3–444,601直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The Series B Convertible Preferred Stock is convertible into shares of Class A common stock, par value $0.0001 per share (the "Common Stock"), of Owlet, Inc. (the "Company"). The conversion rate shall initially be 129.6596 shares of Common Stock per each share of Series B Convertible Preferred Stock, subject to adjustment from time to time pursuant to the terms and conditions of the Investment Agreement, dated February 25, 2024, by and among the Company and Trilogy Equity Partners, LLC ("Trilogy"), amongst others.

表 II 有 1 筆交易的價格引用這則附註。

F3

As set forth in the Warrant to Purchase Shares of Common Stock of Owlet, Inc., dated February 29, 2024, by the Company and Trilogy (the "Warrant"), the exercise price and the number of shares of the Company's Common Stock issuable upon exercise are subject to adjustment upon the occurrence of certain events. As such, the exercise price and the number of shares of Common Stock issuable upon exercise as reported on this Form 4 are subject to change upon the occurrence of future events in accordance with the terms of the Warrant.

表 II 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)